EyeGate Pharmaceuticals Statistics Share Statistics EyeGate Pharmaceuticals has 747.72K
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding 747.72K Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) 8.45% Shares Floating n/a Failed to Deliver (FTD) Shares 1 FTD / Avg. Volume 0.29%
Short Selling Information The latest short interest is 1.33K, so 0% of the outstanding
shares have been sold short.
Short Interest 1.33K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 49.11
Valuation Ratios The PE ratio is 17.54 and the forward
PE ratio is null.
EyeGate Pharmaceuticals's PEG ratio is
0.
PE Ratio 17.54 Forward PE n/a PS Ratio 8.46 Forward PS n/a PB Ratio 5.26 P/FCF Ratio 15.84 PEG Ratio 0
Financial Ratio History Enterprise Valuation EyeGate Pharmaceuticals has an Enterprise Value (EV) of 131.77M.
EV / Sales 8.23 EV / EBITDA 0 EV / EBIT 15.4 EV / FCF 15.41
Financial Position The company has a current ratio of 4.94,
with a Debt / Equity ratio of 0.
Current Ratio 4.94 Quick Ratio 4.94 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF 0.01 Interest Coverage -122.89
Financial Efficiency Return on Equity is 29.99% and Return on Invested Capital is 11.79%.
Return on Equity 29.99% Return on Assets 21.17% Return on Invested Capital 11.79% Revenue Per Employee $1.14M Profits Per Employee $551.77K Employee Count 14 Asset Turnover 0.44 Inventory Turnover n/a
Taxes Income Tax -2.07M Effective Tax Rate -36.49%
Stock Price Statistics The stock price has increased by -1.46% in the
last 52 weeks. The beta is 0.25, so EyeGate Pharmaceuticals's
price volatility has been higher than the market average.
Beta 0.25 52-Week Price Change -1.46% 50-Day Moving Average 35.33 200-Day Moving Average 35.36 Relative Strength Index (RSI) 56.68 Average Volume (20 Days) 350
Income Statement In the last 12 months, EyeGate Pharmaceuticals had revenue of 16.02M
and earned 7.72M
in profits. Earnings per share was 1.99.
Revenue 16.02M Gross Profit 16.02M Operating Income 2.64M Net Income 7.72M EBITDA n/a EBIT 5.64M Earnings Per Share (EPS) 1.99
Full Income Statement Balance Sheet The company has 3.79M in cash and 57.17K in
debt, giving a net cash position of 3.74M.
Cash & Cash Equivalents 3.79M Total Debt 57.17K Net Cash 3.74M Retained Earnings -143.38M Total Assets 34.02M Working Capital 21.83M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 8.56M
and capital expenditures -6.26K, giving a free cash flow of 8.55M.
Operating Cash Flow 8.56M Capital Expenditures -6.26K Free Cash Flow 8.55M FCF Per Share 2.21
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of 16.45% and 48.22%.
Gross Margin 100% Operating Margin 16.45% Pretax Margin 35.33% Profit Margin 48.22% EBITDA Margin n/a EBIT Margin 16.45% FCF Margin 53.39%
Dividends & Yields EYEG pays an annual dividend of $2.25,
which amounts to a dividend yield of 5.86%.
Dividend Per Share $2.25 Dividend Yield 5.86% Dividend Growth (YoY) -4.54% Payout Ratio -126.99% Earnings Yield 5.7% FCF Yield 6.31%
Dividend Details Analyst Forecast Currently there are no analyst rating for EYEG.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number 17.28 Graham Upside -51.56%
Stock Splits The last stock split was on Aug 30, 2019. It was a
backward
split with a ratio of 1:15.
Last Split Date Aug 30, 2019 Split Type backward Split Ratio 1:15
Scores Altman Z-Score -2.64 Piotroski F-Score 6
